Newspaper Clipping of Audited Financials Results for the 4th Quarter and Annual year ended 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Welcure Drugs & Pharmaceuticals has submitted to BSE the newspaper advertisement containing its audited standalone financial results for the fourth quarter and full financial year ended March 31, 2026. This filing is a routine compliance requirement under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, where listed companies must publish their quarterly and annual results in newspapers. The submission is signed by Chintan Ganpat Didawala, Managing Director & CFO. The actual financial figures from the newspaper clipping are not legible in the document provided, so specific revenue or profit numbers cannot be confirmed.
This is a procedural compliance filing and does not by itself change the company's fundamentals. Investors should wait for the detailed audited results announcement or the company's annual report to assess actual financial performance for FY2026.